Relaxin decreases renal interstitial fibrosis and slows progression of renal disease
- 1 March 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 59 (3) , 876-882
- https://doi.org/10.1046/j.1523-1755.2001.059003876.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Changes in collagenases and TGF-β; precede structural alterations in a model of chronic renal fibrosisKidney International, 1999
- Evolution of experimentally induced papillary necrosis to focal segmental glomerulosclerosis and nephrotic proteinuriaAmerican Journal of Kidney Diseases, 1999
- Relaxin is a potent renal vasodilator in conscious ratsJournal of Clinical Investigation, 1999
- Relaxin: A pleiotropic hormoneGeneral Pharmacology: The Vascular System, 1997
- Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo.Journal of Clinical Investigation, 1996
- Relaxin Binds to and Elicits a Response from Cells of the Human Monocytic Cell Line, THP-1Published by Elsevier ,1996
- Expression of transforming growth factor-β isoforms in human glomerular diseasesKidney International, 1996
- Decreased Degradative Enzymes in Mesangial Cells Cultured in High Glucose MediaDiabetes, 1995
- Sustained expression of TGF-β1 underlies development of progressive kidney fibrosisKidney International, 1994
- Measurement of glomerular filtration rate in conscious unrestrained rats with inulin infused by implanted osmotic pumpsAmerican Journal of Physiology-Renal Physiology, 1985